Answers are grounded in this paper and cite their sources.
Background Generalisability of clinical trial outcomes requires inclusion of a diverse study population. Factors that can limit this are geographic location and socioeconomic status. This study investigated the geographic and socio-demographic equity among participants in Australian and United Kingdom (UK)-based ophthalmology clinical trials. Methods We performed a registry-based analysis of ophthalmology clinical trials conducted between 2010 and 2021 and derived the geographic distribution and participant demographics from participating sites. Results 89.1% of recruitment centres in Australia were in metropolitan areas and only 0.8% were in rural areas. Trial participants recruited in New South Wales lived within a mean radius of 21 km of the clinical trial site. 1.4% of participants were recruited from non-metropolitan areas. We found socio-economic disparities among trial participants. 67.9% lived in the least deprived quintile and only 4.2% in most deprived areas. In contrast, UK participants (England and Northern Ireland) were more evenly distributed across with 11.3% from the most deprived and 23.5% from least deprived areas. Decentralised clinical trials (DCTs) in Australia suggested greater inclusion of participants from socioeconomically disadvantaged regions, with 11.1% recruited from the most deprived areas. More than half these participants were residing in rural Australia. Conclusions Representation of trial participants in Australia is limited by the lack of inclusion of participants living in non-metropolitan and least affluent areas. Our results raise the hypothesis that DCTs may help to improve equity in trial participation, particularly in geographically vast countries like Australia, however, further research is needed to fully evaluate the potential benefits.
No takes yet. Share an insight, caveat, or question.
Winklmair et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: